Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Velcade bortezomib: Interim Phase III data

Interim data from the international Phase III VISTA trial in 682 newly diagnosed MM patients showed that Velcade plus

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE